13F Filings History of MIROVA

Latest 13F report
Q3 2025 - 29 Dec 2025
Value $
$707,434,117
Signature - Title
Violaine Olivier Mainguy - CHIEF COMPLIANCE OFFICER
Location
Paris, France
Summary
This page shows a list of all the recent 13F filings made by MIROVA. Form 13F is required to be filed within 45 days of the end of a calendar quarter. MIROVA reported 111 stock holdings with total value $707,434,117 as of Q3 2025. Top holdings included NVDA, MSFT, ECL, ACN, and FSLR.

Notify me when MIROVA files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value

List of Other Managers Reporting for MIROVA:

Name Holdings Value Location File Number
Mirova US LLC $9,902,490,048 Boston, MA 028-20101
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 111 $707,434,117 +$71,179,732 -$94,775,916 -$23,596,184 NVDA, MSFT, ECL, ACN, FSLR 13F-HR 29 Dec 2025, 12:17
Q2 2025 119 $708,801,500 +$147,677,890 -$27,703,950 +$119,973,940 TMO, ECL, NVDA, MSFT, ACN 13F-HR 13 Aug 2025, 16:06
Q1 2025 134 $555,884,538 +$21,576,717 -$17,851,845 +$3,724,872 TMO, ECL, ACN, NVDA, MSFT 13F-HR 14 May 2025, 16:04
Q4 2024 129 $579,516,713 +$67,693,423 -$33,819,512 +$33,873,911 TMO, ACN, ECL, NVDA, MSFT 13F-HR 13 Feb 2025, 16:08
Q3 2024 120 $578,678,314 +$28,808,103 -$33,651,822 -$4,843,719 TMO, ACN, ECL, NVDA, MSFT 13F-HR 13 Nov 2024, 16:09
Q2 2024 123 $547,265,530 +$72,467,632 -$53,546,701 +$18,920,931 TMO, ACN, ECL, NVDA, MSFT 13F-HR 13 Aug 2024, 16:01
Q1 2024 135 $564,513,157 +$118,280,690 -$75,970,678 +$42,310,012 TMO, ACN, ECL, NVDA, MSFT 13F-HR 13 May 2024, 16:00
Q4 2023 126 $488,247,352 +$26,343,513 -$94,820,324 -$68,476,811 TMO, ACN, ECL, GIB, ENPH 13F-HR 13 Feb 2024, 16:00
Q3 2023 163 $496,642,740 +$35,374,334 -$52,257,375 -$16,883,041 TMO, ACN, ENPH, GIB, ECL 13F-HR 14 Nov 2023, 06:42
Q2 2023 163 $568,143,412 +$17,483,136 -$146,293,268 -$128,810,132 TMO, ENPH, ACN, RUN, ECL 13F-HR 11 Aug 2023, 16:11
Q1 2023 164 $693,319,652 +$135,665,807 -$69,634,350 +$66,031,457 TMO, ECL, ENPH, RUN, ACN 13F-HR 12 May 2023, 16:01
Q4 2022 181 $638,758,172 +$50,813,555 -$27,913,793 +$22,899,762 TMO, ECL, RUN, GIB, MSFT 13F-HR 13 Feb 2023, 15:48
Q3 2022 171 $594,320,000 +$50,259,674 -$107,833,092 -$57,573,418 TMO, ECL, RUN, GIB, MSFT 13F-HR 14 Nov 2022, 10:03
Q2 2022 171 $703,657,000 +$99,454,819 -$16,725,722 +$82,729,097 TMO, ECL, RUN, MSFT, GIB 13F-HR 12 Aug 2022, 16:20
Q1 2022 174 $747,078,000 +$96,713,073 -$57,143,258 +$39,569,815 TMO, ECL, RUN, MSFT, GIB 13F-HR 13 May 2022, 16:00
Q4 2021 172 $835,110,000 +$122,286,103 -$34,542,942 +$87,743,161 TMO, ECL, RUN, BLDP, WOLF 13F-HR 14 Feb 2022, 11:19
Q3 2021 165 $777,136,000 +$36,289,231 -$65,152,179 -$28,862,948 TMO, ECL, RUN, BLDP, CREE 13F-HR 12 Nov 2021, 16:02
Q2 2021 165 $834,225,000 +$28,589,062 -$43,381,274 -$14,792,212 TMO, ECL, RUN, BLDP, FSLR 13F-HR 13 Aug 2021, 13:18
Q1 2021 163 $838,103,000 +$174,661,263 -$100,163,918 +$74,497,345 TMO, ECL, RUN, BLDP, FSLR 13F-HR 14 May 2021, 10:53
Q4 2020 163 $777,684,000 +$181,863,320 -$67,013,533 +$114,849,787 ECL, TMO, ITRI, BLDP, RUN 13F-HR 12 Feb 2021, 11:57
Q3 2020 195 $621,246,000 +$137,191,839 -$142,541,074 -$5,349,235 TMO, ECL, VSLR, ITRI, DHR 13F-HR 12 Nov 2020, 15:01
Q2 2020 174 $435,562,000 +$107,836,177 -$6,972,767 +$100,863,410 TMO, ECL, DHR, VSLR, FSLR 13F-HR 13 Aug 2020, 09:35
Q1 2020 173 $264,238,000 +$57,559,963 -$7,201,062 +$50,358,901 TMO, ECL, FSLR, DHR, GIB 13F-HR 14 May 2020, 14:59
Q4 2019 177 $287,350,000 +$29,266,722 -$575,612,466 -$546,345,744 TMO, ECL, DHR, FSLR, GIB 13F-HR 14 Feb 2020, 07:33
Q3 2019 127 $810,998,000 +$12,672,107 -$343,491,282 -$330,819,175 TMO, ECL, DHR, MSFT, MA 13F-HR 13 Nov 2019, 12:19
Q2 2019 128 $1,131,463,000 +$936,801,071 -$2,140,671 +$934,660,400 TMO, ECL, DHR, MA, MSFT 13F-HR 13 Aug 2019, 09:06
Q1 2019 98 $184,372,000 +$26,256,648 -$68,833,452 -$42,576,804 TMO, ECL, GIB, DHR, NVDA 13F-HR 15 May 2019, 08:31
Q4 2018 95 $218,744,000 $0 TMO, ECL, DHR, GIBXXXX, CRTO 13F-HR 14 Feb 2019, 11:57